The Supreme Court of the United States has been asked to take up a case that would potentially define the boundaries of state action antitrust immunity.
Reports say SCOTUS has been asked to take up the North Carolina Board of Dental Examiners’ appeal of an earlier ruling that sided with the US Federal Trade Commission in its challenge against North Carolina’s exclusion of non-dentists from performing teeth whitening procedures. The FTC argued that state-action immunity did not apply in this case on the grounds that the Board of Dental Examiners.
Legal precedent says that private entities must not only show that the policy of immunity must be articulated by the state for that immunity to apply, and that there is active state supervision.
The FTC argued that the Board could not show active state supervision and therefore does not benefit from state immunity as the Board is supervised by its own dentists.
According to the regulator, “Board actions [in the area of teeth whitening[ could be self interested.”
The Fourth Circuit Court of Appeals sided with the FTC, but the Board is now asking the Supreme Court to review the case; reports say the FTC is encouraging Supreme Court justices to deny the case.
Full Content: Washington Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas